KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026)

Johnson & Johnson recorded quarterly Long-Term Deferred Tax of $6.7 billion in Q1 2026, down 2.14% quarter-over-quarter from $6.9 billion in Q4 2025, and down 20.78% year-over-year from $8.5 billion in Q1 2025.

Johnson & Johnson's Long-Term Deferred Tax history runs 18 years deep, the most recent figure standing at $6.7 billion for Q1 2026.

  • In Q1 2026, Long-Term Deferred Tax fell 20.78% year-over-year to $6.7 billion; the TTM figure through Mar 2026 stood at $6.7 billion (down 20.78% YoY), while the FY2025 annual figure was $6.9 billion, down 34.29% from the prior year.
  • Long-Term Deferred Tax came in at $6.7 billion for Q1 2026 at Johnson & Johnson, down from $6.9 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 billion in Q4 2024 to a low of $6.7 billion in Q3 2025.
  • A 5-year average of $8.8 billion and a median of $9.1 billion in 2023 frame the typical range for Long-Term Deferred Tax.
  • Across the five-year window, Long-Term Deferred Tax increased 19.79% in 2022 and slumped 34.29% in 2025, its largest moves.
  • Johnson & Johnson's Long-Term Deferred Tax stood at $9.4 billion in 2022, then slipped by 1.2% to $9.3 billion in 2023, then rose by 12.74% to $10.5 billion in 2024, then plunged by 34.29% to $6.9 billion in 2025, then retreated by 2.14% to $6.7 billion in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $6.7 billion, $6.9 billion, and $6.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 6.73 Bn
Dec 28, 2025 6.87 Bn
Sep 28, 2025 6.67 Bn
Jun 29, 2025 6.80 Bn
Mar 30, 2025 8.49 Bn
Dec 29, 2024 10.46 Bn
Sep 29, 2024 9.35 Bn
Jun 30, 2024 9.00 Bn
Mar 31, 2024 10.31 Bn
Dec 31, 2023 9.28 Bn
Oct 1, 2023 9.26 Bn
Jul 2, 2023 8.78 Bn
Apr 2, 2023 8.82 Bn
Jan 1, 2023 8.95 Bn
Oct 2, 2022 9.39 Bn
Jul 3, 2022 9.51 Bn
Apr 3, 2022 9.94 Bn
Jan 2, 2022 10.22 Bn
Oct 3, 2021 10.65 Bn
Jul 4, 2021 10.80 Bn
Apr 4, 2021 8.32 Bn
Jan 3, 2021 8.53 Bn
Sep 27, 2020 7.82 Bn
Jun 28, 2020 7.81 Bn
Mar 29, 2020 7.54 Bn
Dec 29, 2019 7.82 Bn
Sep 29, 2019 7.70 Bn
Jun 30, 2019 7.65 Bn
Mar 31, 2019 7.53 Bn
Dec 30, 2018 11.41 Bn
Sep 30, 2018 8.08 Bn
Jul 1, 2018 8.47 Bn
Apr 1, 2018 8.79 Bn
Dec 31, 2017 9.90 Bn
Oct 1, 2017 6.30 Bn
Jul 2, 2017 6.11 Bn
Apr 2, 2017 6.38 Bn
Jan 1, 2017 10.14 Bn
Oct 2, 2016 5.90 Bn
Jul 3, 2016 5.78 Bn
Apr 3, 2016 5.68 Bn
Jan 3, 2016 5.49 Bn
Sep 27, 2015 3.15 Bn
Jun 28, 2015 3.09 Bn
Mar 29, 2015 3.06 Bn
Dec 28, 2014 6.20 Bn
Sep 28, 2014 3.35 Bn
Jun 29, 2014 3.38 Bn
Mar 30, 2014 3.69 Bn
Dec 29, 2013 10.84 Bn
Sep 29, 2013 4.60 Bn
Jun 30, 2013 4.74 Bn
Mar 31, 2013 4.51 Bn
Dec 30, 2012 12.10 Bn
Sep 30, 2012 4.23 Bn
Jul 1, 2012 4.01 Bn
Apr 1, 2012 5.91 Bn
Jan 1, 2012 6.54 Bn
Oct 2, 2011 5.56 Bn
Jul 3, 2011 5.65 Bn
Apr 3, 2011 5.33 Bn
Jan 2, 2011 5.10 Bn
Oct 3, 2010 5.18 Bn
Jul 4, 2010 5.11 Bn
Apr 4, 2010 4.91 Bn
Jan 3, 2010 5.51 Bn
Sep 27, 2009 5.89 Bn
Jun 28, 2009 5.87 Bn